(Q44708883)

5 December 2017

title

Comparative varicella vaccine effectiveness during outbreaks in day-care centres (English)

1 reference

5 December 2017

1 reference

M Spackova

1

0 references

author name string

M Wiese-Posselt

2

1 reference

5 December 2017

M Dehnert

3

1 reference

5 December 2017

D Matysiak-Klose

4

1 reference

5 December 2017

U Heininger

5

1 reference

5 December 2017

A Siedler

6

1 reference

5 December 2017

language of work or name

English

0 references

publication date

27 October 2009

1 reference

5 December 2017

1 reference

5 December 2017

volume

28

1 reference

5 December 2017

issue

3

1 reference

5 December 2017

page(s)

686-691

1 reference

THE EPIDEMIOLOGY OF VARICELLA-ZOSTER VIRUS INFECTIONS

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

Live vaccine used to prevent the spread of varicella in children in hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

Varicella vaccination in Japan, South Korea, and Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

Assessing vaccine efficacy in the field. Further observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

Epidemiologic methods in immunization programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

Varicella vaccine effectiveness in the US vaccination program: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

Vaccine effectiveness and severity of varicella among previously vaccinated children during outbreaks in day-care centers with low vaccination coverage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

Use of a computerized database to study the effectiveness of an attenuated varicella vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

Effectiveness of the Oka/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

Varicella vaccine effectiveness during an outbreak in a partially vaccinated population in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

The effectiveness of varicella vaccination during an outbreak in a children's day-care center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

Metaanalysis of vaccine effectiveness in varicella outbreaks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

Chickenpox outbreak in a highly vaccinated school population

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

inferred from DOI database lookup

7 January 2021

based on heuristic

One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

Second varicella vaccine dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

Control of varicella: why is a two-dose schedule necessary?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

Ten year follow-up of healthy children who received one or two injections of varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

Loss of vaccine-induced immunity to varicella over time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

An Outbreak of Varicella among children attending preschool and elementary school in Illinois

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

Younger age at vaccination may increase risk of varicella vaccine failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

Effectiveness over time of varicella vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

An elementary school outbreak of varicella attributed to vaccine failure: policy implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

Importance of catch-up vaccination: experience from a varicella outbreak, Maine, 2002-2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

Vaccine effectiveness during a varicella outbreak among schoolchildren: Utah, 2002-2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

A Retrospective Cohort Study of the Association of Varicella Vaccine Failure With Asthma, Steroid Use, Age at Vaccination, and Measles-Mumps-Rubella Vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

Direct and indirect effects in vaccine efficacy and effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

How reliable is the history of chickenpox? Varicella serology among children up to 14 years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.086

10.1016/J.VACCINE.2009.10.086

7 January 2021

Identifiers

DOI

1 reference

5 December 2017

1 reference